Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
ID: 355190Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $350K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement opportunity titled "Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)." This initiative aims to evaluate the effectiveness of existing Community-Clinical Linkage and Social Connectedness programs in reducing disparities related to diabetes risk factors, incidence, and complications, while also exploring the mechanisms that influence diabetes outcomes. The program is critical for understanding how these interventions can mitigate health disparities and improve health outcomes in communities. The estimated total funding for this program is $3,150,000, with awards ranging from $0 to $350,000, and applications are due by January 6, 2025. For further inquiries, interested applicants can contact Dr. Celeste Sanders at CSanders4@cdc.gov.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    Strengthening and Developing of Sustainable Global Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at strengthening and developing sustainable global public health and epidemiological workforce capacity through collaboration, program development, and implementation. This initiative seeks to address public health workforce development needs, enhance the ability to prevent, detect, and respond to diseases, and strengthen epidemiologic workforce capacity at a global level, particularly in light of recent public health threats such as COVID-19 and Ebola. The total estimated funding for this program is $100 million, with an expected three awards to be made, and applications must be submitted electronically by January 2, 2026, to be considered. For further inquiries, interested applicants can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.
    Strengthening and Development of Sustainable Regional Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at strengthening and developing sustainable regional public health and epidemiological workforce capacity through collaboration, program development, and implementation. This initiative seeks to address public health workforce development needs, enhance the capacity to prevent, detect, and respond to diseases, and improve public health priorities, particularly in light of recent global health threats such as COVID-19 and Ebola. The program will focus on collaboration among public health institutions and Ministries of Health at regional and country levels, with an estimated total funding of $75 million available for three expected awards. Interested applicants can reach out to Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov, with applications due by January 2, 2026, and project start anticipated by September 30, 2026.
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.
    Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Eliminating Parasitic and Neglected Tropical Disease Threats to the United States," aimed at expanding its network of collaborating institutes for research and program support. The initiative seeks to achieve, accelerate, or maintain outcomes for the elimination or control of non-malaria parasitic threats and neglected tropical diseases that impact the health of Americans domestically and internationally. This cooperative agreement has an estimated total program funding of $10 million, with individual awards ranging from $500,000 to $666,667, and is expected to result in three awards. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 1, 2026, and awards anticipated by September 15, 2026.
    Achieving and maintaining sustainable epidemic control through lifesaving HIV/AIDS prevention, care, and treatment services in the Kinshasa and Haut Katanga Regions of the Democratic Republic of Congo (DRC) under PEPFAR
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement to support the provision of lifesaving HIV/AIDS prevention, care, and treatment services in the Kinshasa and Haut Katanga regions of the Democratic Republic of Congo (DRC) under the PEPFAR initiative. The objective of this funding opportunity is to accelerate the delivery of HIV services, particularly targeting individuals unaware of their HIV status, those not receiving treatment, and those in need of preventive services, while also strengthening the technical capacity of local health teams. This initiative is crucial for achieving sustainable epidemic control and aligns with global health strategies aimed at eliminating HIV/AIDS as a public health threat. The estimated total funding for the first year is approximately $13 million, with applications due by February 17, 2026, and the anticipated award date set for September 30, 2026. Interested applicants can reach out to the CDC at pepfarfoas@cdc.gov for further information.
    Economic and Modeling Analyses to Support Immunization Policy and Programs
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement for research projects aimed at developing economic and modeling analyses to support immunization policy and programs. The primary objective is to generate robust data and model-based evidence regarding the public health and economic impacts of vaccines, which will assist decision-makers in enhancing immunization strategies for various populations. This funding opportunity is critical for addressing the burden of vaccine-preventable diseases and promoting cost-effective vaccination interventions, ultimately aiming to save lives and reduce healthcare costs. The estimated total program funding is $3,750,000, with individual awards ranging from $500,000 to $750,000, and applications are due by March 1, 2026. For further inquiries, interested applicants can contact Amy Yang at AYang@cdc.gov or by phone at 404-718-8836.
    Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.
    Improving HIV treatment in the Dominican Republic (DR) under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement to improve HIV treatment in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR). The primary objective of this funding opportunity is to enhance access to HIV testing, provide effective HIV treatment and TB preventive therapy, and ensure that individuals living with HIV are retained on lifelong quality treatment to achieve viral suppression. This initiative is particularly important for communities in the Dominican Republic, including Haitian migrants and their descendants, who are significantly affected by HIV. Interested applicants can reach out to the CDC at pepfarfoas@cdc.gov for more information, with an estimated total funding amount of $5,600,000 for the first fiscal year and a deadline for applications set for February 17, 2026.